Full-Time

Associate Director

Protein Engineering and Structural Biology

Posted on 5/30/2024

Absci

Absci

51-200 employees

Generative AI drug creation and biologics acceleration

AI & Machine Learning
Data & Analytics
Biotechnology

Senior

Vancouver, WA, USA

Requirements
  • Ph.D. in life sciences with a minimum of 8 years of experience or Master's Degree with equivalent experience
  • Experience in protein engineering, structural biology, biologics discovery, assay development, and lead candidate profiling
  • Experience managing teams of PhD-level scientists and research associates
  • Track record of high-quality publications in peer-reviewed journals and/or relevant patent filings
  • Strong knowledge in structural biology, biophysics, or adjacent areas
  • Deep scientific expertise in the biopharma R&D process
  • Experience using innovative technologies, platforms, and modalities to advance novel drug candidates
  • Excellent leadership skills
  • Excellent oral, written, and interpersonal communication skills
  • Ability to collaborate with a team and think creatively as an individual
  • Demonstrated interpersonal communication and leadership skills, including conflict management and trust building
Responsibilities
  • Lead Protein Engineering and Structural Biology Team to make significant antibody engineering contributions to all internal and external drug creation programs
  • Lead antibody engineering efforts to ensure the achievement of experimental milestones such as hit discovery, lead optimization, and functional validation
  • Mentor teams on themes in protein engineering and share expertise to improve team performance
  • Work closely with the AI team to synchronize strategies for a generative AI drug creation platform
  • Support efficient antibody selection technology for the generative AI platform and develop a structure-based rational engineering platform for antibody engineering
  • Hold the team's work to high standards, report delays promptly, and improve experimental strategies
  • Lead and contribute to scientific excellence through publications and patents
  • Develop novel technologies and inventions to advance drug discovery processes

Absci is an innovative generative AI drug creation company that rapidly transforms AI-designed antibodies into wet lab-validated drug candidates, with processes taking as little as six weeks. By merging AI with synthetic biology, this leader in biotechnology not only speeds up the drug discovery process but also enhances the ability to produce effective biologics efficiently. A career here offers a chance to be at the forefront of applying cutting-edge technology to solve real-world health challenges, making it a compelling environment for those passionate about pioneering advancements in medicine.

Company Stage

IPO

Total Funding

$324.3M

Headquarters

Vancouver, Washington

Founded

2011

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

-16%

2 year growth

-16%
INACTIVE